This article explores how counterfeiters are exploiting gaps in healthcare packaging and supply chains. It examines why traditional safeguards are no longer enough and how digital authentication, track-and-trace systems and smarter packaging could he
ICMR researchers reveal a clear mortality risk linked to drug-resistant infections in a major new study. The findings show these infections raise death rates, treatment costs, and hospital stays across Indian tertiary hospitals
H1N1 Alert measures are being stepped up across Haryana as flu cases rise sharply in neighboring Delhi. The state has ordered wider influenza testing and stronger hospital preparedness. The H1N1 Alert comes as Delhi has reported 1,777 H1N1 cases...
A H1N1 Alert has prompted a key health review meeting in Delhi. Health Minister Dr Pankaj Kumar Singh will lead the meeting at the Delhi Secretariat this afternoon. The H1N1 Alert comes as officials review hospital preparedness and testing measures
The latest drug recall by Sun Pharmaceutical Industries has drawn attention to a manufacturing quality issue involving its epilepsy medicine carbamazepine
Mosquito-borne diseases have prompted Kerala to intensify prevention, surveillance and community action across the state. Health Minister K Muraleedharan has urged residents to support measures against dengue, chikungunya and malaria
Fake medicines remain a serious threat to India’s pharmaceutical ecosystem, even as regulators continue to tighten drug-control measures and enforcement
Amylyx Pharmaceuticals’ low blood sugar drug avexitide has delivered strong results in a late-stage trial. The experimental treatment cut hypoglycemic episodes by 55 percent versus placebo. The results came from a 78-patient trial involving people...
CDMO platform expansion is gaining momentum at Piramal Pharma as the company takes majority control of Yapan Bio, the transaction turns Yapan Bio into a subsidiary and strengthens Piramal Pharma’s capabilities in vaccine and biologics development
FDA observation outcomes at Aurobindo Pharma's Raleigh facility have moved into a new phase after the US regulator classified the site as Voluntary Action Indicated
.jpg)
, CDSCO.jpg)